Diagnostic News and Research

RSS

Study reveals improved process to obtain, store RNA from lung tumor biopsies

Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.

16 Jul 2010

New radiation mechanism that targets cancer may someday help clean up environmental disasters: Study

Radiation similar to that used to treat cancer may someday help clean up environmental disasters such as the Gulf oil spill and detect explosive powder hidden underneath clothing.

16 Jul 2010

ALOKA announces new ProSound F75 high-end color diagnostic ultrasound system

ALOKA CO., LTD., announced on July 16 the ProSound F75, a high-end color diagnostic ultrasound system of the new "F" series at its private exhibition, "Aloka Fair 2010." This new flagship of multi-purpose systems, providing unprecedented performance in a variety of clinical applications, is comfortable and easy to use.

16 Jul 2010

An overview of heart palpitations from Mayo Clinic

Almost everyone feels occasional heart palpitations -- a change in the heart's rhythm. Palpitations range from what feels like a skip, flip or bump in the heart's rhythm to a sustained, racing heartbeat.

16 Jul 2010

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

Meningiomas, the most common type of brain tumors, are rarely cancerous and may not require treatment. The July issue of Mayo Clinic Health Letter offers an overview of this brain tumor that is usually benign.

16 Jul 2010

Duke University researchers, African colleagues to study malaria control strategies

A team of Duke University researchers and African colleagues will be studying strategies to curb the spread of malaria while protecting human and environmental health. The work in regions where the potentially deadly, mosquito-borne disease occurs will be supported by a $2.2 million, four-year grant from the U.S. National Institutes of Health.

16 Jul 2010

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

This week, nearly 4,000 scientists from around the world gathered to report and discuss the latest advances in research on treatments, risk factors, and diagnosis for the health epidemic of the 21st century – Alzheimer's disease – at the Alzheimer's Association's 2010 International Conference on Alzheimer's Disease in Honolulu.

15 Jul 2010

National Jewish Health named #1 respiratory hospital in the nation

For the 13th consecutive year, National Jewish Health has been named the #1 respiratory hospital in the nation by U.S. News & World Report.

15 Jul 2010

ALLOZYNE signs worldwide licensing agreement with The Scripps Research Institute

ALLOZYNE Inc. announced today the signing of a worldwide licensing agreement with The Scripps Research Institute. The agreement gives ALLOZYNE rights to a unique and powerful chemical reaction, developed by Nobel Laureate K. Barry Sharpless of Scripps Research, known as "Click chemistry." The novelty of this reaction comes from its ability to introduce two different molecular components and have them "click" together stably and irreversibly.

15 Jul 2010

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

IBM today announced plans to enlist some of the company's leading scientists and technologists to help medical practitioners and insurance companies provide high-quality, evidence-based care to patients. As part of this initiative, IBM is collaborating with clinicians in medical institutions and hiring medical doctors to work alongside its researchers to develop new technologies, scientific advancements and business processes for healthcare and insurance providers.

15 Jul 2010

Eurotech announces $1.2M contract to supply embedded computers to medical OEM

Eurotech, a leading supplier of embedded technologies, products, and systems, today announces a 1.2 Million USD contract to supply embedded computers to a leading medical original equipment manufacturer (OEM) that specializes in blood management and cardiopulmonary devices. The two-year contract will allow the customer to meet market demand for blood diagnostic equipment with the Eurotech TurboXb computer on module.

15 Jul 2010

MEDTOX Scientific second-quarter total revenues increase 18.1% to $25.2 million

MEDTOX Scientific, Inc. today announced results for the second quarter ended June 30, 2010. MEDTOX achieved a significant increase in new clinical laboratory business for the quarter ended June 30, 2010, and laboratory drugs-of-abuse testing showed a net positive increase in revenues of 5.6% for the second quarter of 2010, compared to a decrease of 10.6% in the prior year quarter.

15 Jul 2010

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the results of recent testing of the unique PVA film formulation produced by Lanzhou Sanhuan New Technology Development Ltd. of Ganzu, China. Earlier this week, Biomagnetics announced its intent to acquire Lanzhou as the first of several planned acquisitions to be done at a $1.00 share price valuation for Biomagnetics Diagnostics' common shares.

15 Jul 2010

NUHW files for union election, but refuses to sign agreement

Two weeks after filing for a union election among 46,000 Kaiser workers in California, the National Union of Healthcare Workers (NUHW) refused to sign an agreement that would allow the election to go forward in the next 60 days.

15 Jul 2010

Lantheus Medical Imaging, JBCPL partner to launch DEFINITY ultrasound contrast imaging agent in India

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the launch of its ultrasound contrast imaging agent, DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, in India. The company has signed a multi-year agreement with Mumbai-based J.B. Chemicals & Pharmaceuticals, Ltd. for the distribution and marketing of DEFINITY® in the Indian marketplace.

15 Jul 2010

Lakeridge Health, UHN announce shared management of Laboratory Services

Kevin Empey, President and CEO of Lakeridge Health and Dr. Robert Bell, CEO of the University Health Network are proud to announce the shared management of LH's Laboratory Services with those of UHN. UHN's laboratory currently manages all services for Princess Margaret Hospital, Toronto Western Hospital and Toronto General Hospital, and 13 other hospitals. Laboratory services will continue to be provided in the LH laboratory while being managed by UHN administrative, clinical, and quality experts.

15 Jul 2010

Keck School of Medicine receives grant for research on biomarker impact on breast cancer screening

Researchers at the Keck School of Medicine of the University of Southern California (USC) will test whether a set of blood-based biomarkers can assist mammography in the early detection of breast cancer with a $180,000 grant announced today from Susan G. Komen for the Cure®. The grant will fund research into whether specific biomarkers, or minute substances in the blood, can effectively distinguish breast cancer patients from their healthy counterparts and whether an inexpensive, less invasive screening strategy can be developed based on this approach.

15 Jul 2010

Genelex, Helix announce strategic alliance to increase availability of new DNA Drug Sensitivity Tests

Genelex and Helix have announced a personalized prescribing strategic alliance to increase the availability of important new DNA Drug Sensitivity Tests such as Plavitest and Tamoxitest. These tests and the GeneMedRx medication management software can save lives and healthcare dollars by allowing doctors to personalize their prescribing practices in order to prevent adverse medication outcomes, including treatment failures and dangerous side effects.

15 Jul 2010

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced that the Company's subsidiary, CardioGenics Inc., has entered into an agreement with Merck Chimie S.A.S. to adopt its proprietary biological-linking technology to Merck-supplied magnetic beads designed to increase yields in antibody manufacturing.

15 Jul 2010

Pacific Biosciences completes $109M Series F financing round

Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today announced it has completed a Series F round of financing in the amount of $109 million.

14 Jul 2010

Diagnostic News and Research

Study reveals improved process to obtain, store RNA from lung tumor biopsies

New radiation mechanism that targets cancer may someday help clean up environmental disasters: Study

ALOKA announces new ProSound F75 high-end color diagnostic ultrasound system

An overview of heart palpitations from Mayo Clinic

Meningiomas account for about 25% of primary brain tumors: Mayo Clinic Health Letter

Duke University researchers, African colleagues to study malaria control strategies

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

National Jewish Health named #1 respiratory hospital in the nation

ALLOZYNE signs worldwide licensing agreement with The Scripps Research Institute

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

Eurotech announces $1.2M contract to supply embedded computers to medical OEM

MEDTOX Scientific second-quarter total revenues increase 18.1% to $25.2 million

Biomagnetics Diagnostics reports positive test results of unique PVA film formulation

NUHW files for union election, but refuses to sign agreement

Lantheus Medical Imaging, JBCPL partner to launch DEFINITY ultrasound contrast imaging agent in India

Lakeridge Health, UHN announce shared management of Laboratory Services

Keck School of Medicine receives grant for research on biomarker impact on breast cancer screening

Genelex, Helix announce strategic alliance to increase availability of new DNA Drug Sensitivity Tests

CardioGenics Holdings' subsidiary signs second product agreement with Merck Chimie

Pacific Biosciences completes $109M Series F financing round

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News